Daniel P. Gross

Daniel P. Gross

@danielpgross.bsky.social

Prof at @DukeFuqua, formerly @HarvardHBS @UCBerkeley. Studying how crisis R&D, tech policy, automation affect firms & economies. http://dpgross.com

1.8K followers300 following21 posts

📢 Conference announcement! Paolo Surico and I are excited to be organizing this @cepr.org conference on Public Policies for Innovation. If you work in the #Economics of #Innovation and #InnovationPolicy, please submit + spread the word. Non-presenting attendees also invited.

#CallForPapers - Conference on Public Policies for Innovation ESRC, London Business School, @fuqua.duke.edu & CEPR invite submissions for a #conference on Public Policies for Innovation at LBS on 19-20 March 2026. cepr.org/events/confe... Organisers: Paolo Surico & @danielpgross.bsky.social #EconSky

Proud to have worked with this crew, especially Justin Walthier and Hana Ryan, who are both legal prodigies. Thanks to @prmalone.bsky.social, Nina Srejovic, and @stanfordlaw.bsky.social for support, and to @patentscholar.bsky.social for making this happen. We hope the court finds the brief helpful.

Lisa L. Ouellette@patentscholar.bsky.social

Thanks to @prmalone.bsky.social and his team at the @juelsgaardclinic.bsky.social at @stanfordlaw.bsky.social for filing this amicus brief on behalf of myself, @pierre-azoulay.bsky.social, @danielpgross.bsky.social & @sampat.bsky.social in the NIH indirect costs case papers.ssrn.com/sol3/papers....

This is a thoughtful take worth a full read. Despite all the hot takes I find it hard to have a point of view over the specific faults or appropriate remedies (individual to the author, or systemic) until we know more about what happened.

This post is unavailable.

Also find it hard to believe a complex paper like this was made up from whole cloth... but could be wrong. Retraction + expulsion clearly points to major misconduct of some kind. I prefer facts over speculation--we'll get them eventually. For now the key thing to do is just to stop citing the paper!

Daniel P. Gross reposted

Reviewing the history of US indirect cost recovery policy, presenting new data on indirect cost recovery rates, modeling the effects of a 15 percent cap at the NIH, and evaluating tradeoffs across reform options, from Azoulay, Gross, and Sampat https://www.nber.org/papers/w33627

Daniel P. Gross reposted

Tariffs get all the attention, but ask economists what they're really worried about and many will point to the Trump administration's cuts to federal support for the sciences, including canceling grants and revoking student visas. #EconSky www.nytimes.com/2025/03/31/b...

nytimes.comTrump’s Science Policies Pose Long-Term Risk, Economists Warn (Gift Article)Since World War II, U.S. research funding has led to discoveries that fueled economic gains. Now cutbacks are seen as putting that legacy in jeopardy.

Daniel P. Gross reposted

The US WW2 medical research and development effort catalyzed postwar science, modernized drug discovery, and fueled the postwar National Institutes of Health — reshaping biomedical innovation for decades, from Daniel P. Gross and Bhaven N. Sampat https://www.nber.org/papers/w33457

Daniel P. Gross reposted

Daniel P. Gross reposted

A good summary of what's gone on with NSF funding, and some interesting new tidbits. I'm really pleased they chose to end with @wytham88.bsky.social and a link to our paper: “Grants don’t just generate knowledge or output now, they’ve become a way that we support the training of future scientists.”

Dan Garisto@dangaristo.bsky.social

NEW: We obtained the directions NSF program officers are following to review all grants for compliance with the Trump EOs and the turmoil it has created in an agency mandated to broaden STEM participation. Our story: www.nature.com/articles/d41...

Daniel P. Gross reposted

Replying to @danielpgross.bsky.social

Full thread coming soon. If you want a break from current events, come see the talk at the Virtual Seminar on Innovation and Economic Growth this Wednesday 12pm ET! sites.google.com/view/v-s-inn... Kudos to Alex and Murat for creating a new seminar 💪

sites.google.comVSIEG2025 Winter Schedule: Wednesdays at 12 noon - 1pm Eastern Time. February 5th - Dan Gross (Duke) "The Therapeutic Consequences of the War: World War II and the 20th Century Expansion of Biomedicine ...
View full thread

Paper highlights the potential long-run impacts of integrated, cross-sectoral biomed. R&D policy focused on solving problems--complementing traditional NIH approach of funding undirected science. Echoes in the Covid era, which may have heralded a new golden age: www.nytimes.com/2023/06/23/m...

nytimes.comSuddenly, It Looks Like We’re in a Golden Age for Medicine (Published 2023)We may be on the cusp of an era of astonishing innovation — the limits of which aren’t even clear yet.

Full thread coming soon. If you want a break from current events, come see the talk at the Virtual Seminar on Innovation and Economic Growth this Wednesday 12pm ET! sites.google.com/view/v-s-inn... Kudos to Alex and Murat for creating a new seminar 💪

sites.google.comVSIEG2025 Winter Schedule: Wednesdays at 12 noon - 1pm Eastern Time. February 5th - Dan Gross (Duke) "The Therapeutic Consequences of the War: World War II and the 20th Century Expansion of Biomedicine ...

Daniel P. Gross reposted

It's such a weird thing to hear the news and think "that's bad, but also I have a paper about (an aspect) of that" Funding delays are really not great for people who work in science. Funding delays of > 30 days lead to: - 40% increase in scientists exiting US labor force - 20% decrease in wages

Carl Zimmer@carlzimmer.com

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring www.science.org/content/arti...

Daniel P. Gross reposted

Daniel P. Gross reposted

A golden age not only for antibiotics but also other drugs, and biomedicine broadly -- new paper on the links of this prolific era to the WW2 research effort (& the limits to those links) coming shortly. Lots to think about in the way of possible parallels in the aftermath of Covid and OWS.

Saloni@scientificdiscovery.dev

Many people talk about the "Golden Age of Antibiotics", but I hadn't seen it visualized properly. Just how many types of antibiotics were discovered during that time? So, I visualized it myself!

Had a great chat with Jordi @visiblehandpod.bsky.social a couple weeks ago on our work on telephone industry automation - though one thing you won't get to experience thru the podcast format is my office old school rotary dial telephone!

The Visible Hand Podcast@visiblehandpod.bsky.social

Episode 86: Dan Gross on Labour Market Responses to Automation. #EconSky. Listen here at: www.thevisiblehand.uk/episodes/epi...

Daniel P. Gross reposted

You are up to date.